Orthopedics SMEs and Pharmaceutical Giants in Switzerland

Pierre-Yves Donzé ()
Additional contact information
Pierre-Yves Donzé: Osaka University

Chapter Chapter 7 in Medtech, 2022, pp 153-171 from Springer

Abstract: Abstract Switzerland is a small, open economy, and its medtech industry is one of the most integrated in the existing global networks. An examination of M&A activity shows the prominent presence of foreign (mostly US and German) firms in Switzerland, while the pharmaceutical giants (Roche and Novartis) expanded their medtech divisions via takeovers of numerous firms around the world. Foreign trade statistics capture the specialization of the Swiss medtech industry and its high-level competitiveness in the field of orthopedic equipment. In analyzing the sources of this comparative advantage, this chapter demonstrates the establishment of a cluster of firms active in the manufacturing of implants since the late 1950s, along with their growth in the global market, thanks to cooperation with Swiss universities and research institutes.

Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-981-16-7174-6_7

Ordering information: This item can be ordered from
http://www.springer.com/9789811671746

DOI: 10.1007/978-981-16-7174-6_7

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().